In this exploratory study, utilization of kidneys from HCV-infected donors to expand the donor pool appears to be an acceptable option to patients.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: